HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CHPA/Nevada AG Meth Retail Education Poster Campaign Under Way

This article was originally published in The Tan Sheet

Executive Summary

Unusually large retail purchases of OTC cold, allergy, sinus and asthma medicines may signify the items are being used to produce methamphetamine in an illegal lab, recently distributed posters warn retail store clerks.

You may also be interested in...



Meth class

CHPA in discussion with states of Washington, Oregon, Missouri about education programs on laws limiting OTC purchases of potential methamphetamine precursors. Trade association is launching effort in Arkansas this month, where new law limits amount of ephedrine, pseudoephedrine or PPA that may be purchased in one transaction to three packages or 9 g, whichever is smaller; bill also prohibits sales to minors. Program includes seminars in collaboration with DEA, state Health Department, as well as educational posters and brochures distributed to pharmacies. CHPA conducted similar retailer education program in Nevada last year (1"The Tan Sheet," June 5, 2000, p. 6)

Meth Abuse Education Program To Begin Regionally, CHPA Says

A Consumer Healthcare Products Association-sponsored program to educate teenagers about the dangers of methamphetamine abuse should commence regionally in Atlanta, St. Louis and San Diego at the end of the year or in early 2002 and will eventually expand nationwide.

Anti-meth bill

Methamphetamine legislation expected to be signed by President Clinton as part of the Children's Health bill (HR 4365). The rider to the omnibus bill aimed at continuing programs for children - including support and education for folic acid/neural tube defect programs - limits sales of OTC ephedrine, pseudoephedrine and phenylpropanolamine products and toughens penalties for violations (1"The Tan Sheet" June 5, p. 6)

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel